Purchase of Rare or Inherited Disease Test Directory testing for Welsh patients
In-line with All Wales Medical genomic Service’s (AWMGS) commissioning model, AWMGS will procure from CeGaT whole exom sequencing (WES) for trio or singleton virtual panel analysis, MLPA and single gene testing for patients where this testing cannot be accessed within the NHS E laboratory network. This genetic testing will ensure equity of access to genomic testing for Welsh patients and meet their need to seek a timely genetic diagnosis for their rare or inherited disease.
Buyer
NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)
Value
£660,000
Published
15 May 2024
Closes
15 May 2024
Procurement details
Source
Sell2Wales
Region
United Kingdom
Procurement method
Limited
Category
Goods
Contract starts
Not provided
Contract ends
Not provided
CPV classifications
33910000
Pathology dissection instruments and supplies
Lots
Lot 1 Purchase of Rare or Inherited Disease Test Directory testing for Welsh patients
£660,000
NWSSP Procurement Services intends to award a contract on behalf of Cardiff and Vale University Health Board, AWMGS, for the supply of whole exom sequencing (WES) for trio or singleton virtual panel analysis, MLPA and single gene testing from CeGAT. The contract is estimated to commence in June 2024, for a period of two years.
Delivery: Cardiff and Vale of Glamorgan
Documents
Unlock document linkPurchase of Rare or Inherited Disease Test Directory testing for Welsh patients
Not provided
In-line with All Wales Medical genomic Service’s (AWMGS) commissioning model, AWMGS will procure from CeGaT whole exom sequencing (WES) for trio or singleton virtual panel analysis, MLPA and single gene testing for patients where this testi...
Award notice · Web page
Contains public sector information licensed under the Open Government Licence v3.0.